PubRank

David Laharie

Author PubWeight™ 29.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology 2011 3.81
2 Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. Gastroenterology 2013 3.45
3 Infliximab plus azathioprine for steroid-dependent Crohn's disease patients: a randomized placebo-controlled trial. Gastroenterology 2006 2.91
4 Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006 2.37
5 Saccharomyces boulardii does not prevent relapse of Crohn's disease. Clin Gastroenterol Hepatol 2013 1.50
6 Efficacy and safety of adalimumab 80 mg weekly in luminal Crohn's disease. Inflamm Bowel Dis 2015 1.38
7 A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization. Am J Gastroenterol 2010 1.22
8 Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy. Clin Gastroenterol Hepatol 2010 1.15
9 Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease. Inflamm Bowel Dis 2014 0.95
10 Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients. Eur J Gastroenterol Hepatol 2002 0.95
11 Helicobacter pullorum cytolethal distending toxin targets vinculin and cortactin and triggers formation of lamellipodia in intestinal epithelial cells. J Infect Dis 2014 0.94
12 Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype. Am J Surg Pathol 2008 0.90
13 Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease. Inflamm Bowel Dis 2012 0.88
14 Risk of herpes zoster in patients receiving anti-TNF-α in the prospective French RATIO registry. J Invest Dermatol 2011 0.88
15 Portomesenteric vein thrombosis in patients with inflammatory bowel disease. Inflamm Bowel Dis 2013 0.84
16 The management of immunosuppression in patients with inflammatory bowel disease and cancer. Gut 2013 0.83
17 Adherence to adalimumab therapy in Crohn's disease: a French multicenter experience. Inflamm Bowel Dis 2011 0.82
18 Isolated idiopathic chronic pancreatitis associated with a compound heterozygosity for two mutations of the CFTR gene. Gastroenterol Clin Biol 2003 0.80
19 Efficacy of intravenous cyclosporin in moderately severe ulcerative colitis refractory to steroids. Gastroenterol Clin Biol 2005 0.79
20 Bifidobacterium breve and Streptococcus thermophilus secretion products enhance T helper 1 immune response and intestinal barrier in mice. Exp Biol Med (Maywood) 2005 0.78
21 Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy. Inflamm Bowel Dis 2016 0.76
22 Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn's disease: results from a prospective study. Inflamm Bowel Dis 2011 0.76
23 [Fascioliasis: a 23-year retrospective study]. Presse Med 2007 0.75
24 [First line therapy of inflammatory bowel disease]. Rev Prat 2014 0.75
25 Pattern and Severity of Psoriasiform Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF alpha Inhibitors. Acta Derm Venereol 2017 0.75
26 Paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome: therapeutic challenge with bone marrow transplantation, transjugular intrahepatic portosystemic shunt, and vena cava stent. Eur J Gastroenterol Hepatol 2005 0.75
27 [Infliximab therapy in Crohn's disease complicated by Listeria monocytogenes meningoencephalitis]. Gastroenterol Clin Biol 2006 0.75
28 Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis 2017 0.75
29 Quality of Sex Life in Patients with Inflammatory Bowel Disease: The Gastroenterologists' Perspective. Inflamm Bowel Dis 2017 0.75
30 [Brief intervention about alcohol use]. Presse Med 2009 0.75
31 Endoscopy in inflammatory bowel disease: recommendations from the IBD Committee of the French Society of Digestive Endoscopy (SFED). Endoscopy 2013 0.75